|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.147 USD | +0.99% |
|
-2.65% | -24.62% |
| Apr. 15 | CytoDyn Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
| Mar. 05 | Transcript : CytoDyn Inc. - Special Call |
CytoDyn Inc. reported earnings results for the full year ended May 31, 2022. For the full year, the company reported sales was USD 0.266 million. Net loss was USD 210.82 million compared to USD 176.47 million a year ago.
Basic loss per share from continuing operations was USD 0.31 compared to USD 0.3 a year ago. Diluted loss per share from continuing operations was USD 0.31 compared to USD 0.3 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.62% | 145M | |
| +5.66% | 109B | |
| +11.23% | 105B | |
| -0.38% | 22.25B | |
| -12.15% | 22.09B | |
| -7.66% | 18.68B | |
| -36.52% | 17.58B | |
| -10.09% | 16.85B | |
| +3.33% | 13.76B | |
| +36.58% | 12.46B |
CYTODYN INC. 
